Literature DB >> 15758775

Characterization of localized seminal vesicle amyloidosis causing hemospermia: an analysis using immunohistochemistry and magnetic resonance imaging.

Seiji Furuya1, Naoya Masumori, Ryoji Furuya, Taiji Tsukamoto, Hiroshi Isomura, Mitsuharu Tamakawa.   

Abstract

PURPOSE: We evaluated the characteristics of seminal vesicle amyloidosis (SVA) associated with hemospermia by immunohistochemistry and magnetic resonance imaging (MRI) as well as the clinical course of hemospermia.
MATERIALS AND METHODS: Of 56 patients with hemospermia 12 underwent transperineal biopsy of the seminal vesicle under transrectal ultrasound monitoring. SVA was proved in 4 men 48 to 59 years old by histological and immunohistochemical examinations of specimens obtained by biopsy. Two men presented with the first episode of hemospermia and 2 presented with recurrent hemospermia. MRI at 1.5 Tesla was performed while hemospermia persisted and after its resolution. Patients were followed for 10 to 86 months with regard to the duration of hemospermia, the time of its resolution and its recurrence.
RESULTS: Amyloid deposits in the subepithelial tissue of the seminal vesicles were permanganate sensitive, and positive for lactoferrin and the amyloid P component but negative for amyloid A protein, lambda and kappa chains, and beta2-microglobulin. The seminal vesicles with obvious intravesicular hemorrhage on needle puncture were hyperintense on T1-weighted images. After hemospermia resolution T1-weighted images became diffusely hypointense. T2-weighted images were of low intensity, representing amyloid deposits. Hemospermia resolved spontaneously in all patients in an average of 14 months. Although disease recurred in 1 patient after 8 months of resolution, it disappeared after 11 months of recurrence.
CONCLUSIONS: Localized SVA with hemospermia shows hypointensity on T2-weighted MRI. Hemospermia is spontaneously resolved with the transition from hyperintense to hypointense T1-weighted MRI.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15758775     DOI: 10.1097/01.ju.0000152291.44802.9f

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Seminal Tract Amyloidosis: Synchronous Amyloidosis of the Seminal Vesicles, Deferent Ducts and Ejaculatory Ducts.

Authors:  Lea Rath-Wolfson; Golan Bubis; Shmuel Shtrasburg; Asaf Shvero; Rumelia Koren
Journal:  Pathol Oncol Res       Date:  2017-01-17       Impact factor: 3.201

2.  Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies--are routine investigations for systemic amyloidosis warranted?

Authors:  Zichu Yang; Alexander Laird; Ashley Monaghan; Morag Seywright; Imran Ahmad; Hing Y Leung
Journal:  Asian J Androl       Date:  2012-12-10       Impact factor: 3.285

Review 3.  Lesions of the Seminal Vesicles and their MRI Characteristics.

Authors:  Mahati N Reddy; Sadhna Verma
Journal:  J Clin Imaging Sci       Date:  2014-10-31

Review 4.  Detecting diseases of neglected seminal vesicles using imaging modalities: A review of current literature.

Authors:  Gautam Dagur; Kelly Warren; Yiji Suh; Navjot Singh; Sardar A Khan
Journal:  Int J Reprod Biomed (Yazd)       Date:  2016-05

5.  Localized amyloidosis of the epididymis: a previously unreported phenomenon.

Authors:  Lucio Díaz-Flores; Ricardo Gutiérrez; Ma Del Pino García; Manuel Jose Gayoso; Jose Luis Carrasco; Lucio Díaz-Flores; Hugo Álvarez-Argüelles
Journal:  Diagn Pathol       Date:  2017-08-04       Impact factor: 2.644

Review 6.  Etiologic classification, evaluation, and management of hematospermia.

Authors:  Yiji Suh; Jason Gandhi; Gunjan Joshi; Min Yea Lee; Steven J Weissbart; Noel L Smith; Gargi Joshi; Sardar Ali Khan
Journal:  Transl Androl Urol       Date:  2017-10

7.  Hemosepermia after transrectal ultrasound-guided prostatic biopsy: A prospective study.

Authors:  M Abdelkhalek; M Abdelshafy; H Elhelaly; M Kamal
Journal:  Urol Ann       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.